For the last 20 years, researchers have focused on amyloid beta peptides and the “plaque” they sprout in diseased brains as the main target of Alzheimer’s research. But the pace of progress in treating—not to mention curing—the debilitating, neurodegenerative disease has been painfully slow.
from Dementia Big http://ift.tt/2dKbhQk via alcoholic dementia
http://ift.tt/2dOsaP1
No comments:
Post a Comment